Investigational Treatment Regimen Could Expand Options for Virologically Suppressed Adults –– Positive Phase 3 Results from ...

The World Health Organization has revised its guidelines to say that every person infected with HIV should now be given powerful anti-AIDS drugs.... World Health Organization Posts Ambitious New ...

Gilead Sciences, Inc. GILD announced that the investigational single-tablet regimen of bictegravir and lenacapavir for the ...

Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...

Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. Researchers ...

Drug-related problems in HIV treatment are prevalent, affecting treatment effectiveness and safety, with 99.7% of patients experiencing at least one DRP. Treatment safety was the most frequent problem ...

Summary Box: CDC recommends HIV drug treatment for all people exposed to virusWith BC-HIV Guidelines, BjtCHANGING PRACTICES: The government recommended for the first time that rape victims and certain ...

The recommended change would mean that patients would begin treatment before they get extremely sick. In Africa, where millions of people are... South Africa Weighs Starting HIV Drug Treatment Sooner ...

In a person living with HIV, proviruses—strands of HIV DNA—are typically integrated into the T cell genome and become a ...

In the region, the definition of “high-risk drug use”/“problem drug use” is limited to “current injecting drug use” due to ...